Soon, new drug may help cure type 2 Diabetes at source

Image
ANI Washington
Last Updated : Oct 06 2014 | 3:25 PM IST

A Rutgers researcher is developing a new drug that might help in battling against the type 2 diabetes, which would attack the root cause of the disease.

New research shows promising evidence that a modified form of a different drug, niclosamide, now used to eliminate intestinal parasites, might hold the key to battling the disease at its source.

Victor Shengkan Jin said it was important to find a suitable medication to correct the cause of the disease as quickly as possible because the only way now known to "cure" the condition involves major gastric bypass surgery.

The modified medication, whose full name is niclosamide ethanolamine salt (NEN), burned the excess fat in liver cells through a process known as mitochondrial uncoupling. Mitochondria are the microscopic energy source for each cell in the body, and ordinarily, like a well-tuned car engine, they burn fuels including fats and sugars in modest quantities to keep the cells functioning.

Jin also mentioned that it was significant that the drug he used was a modified form of a medication that the FDA already approved for human use, so it was a deliberate choice.

.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 06 2014 | 3:18 PM IST

Next Story